Bioplus is a family majority owned business with over 500 employees, multiple manufacturing sites and business in over 50+ countries. Our products are focused on naturally sourced, renewable resource compounds validated by advanced science. Our focus is on licensed and OTC (nutritional) pharmaceuticals or healthcare products, novel drug delivery, excellence in carbohydrate chemistry and biopharmaceuticals.
Our 70+ years of tradition, trust and reliability is supported by our desire to look further, take a long-term view and be flexible in our understanding of changing needs. Our challenge in the next millennium remains to focus successfully on meeting the aspirations of our employees and our customers, whilst balancing our increasingly research driven environment. Our only competitive advantage remains to "Think Ahead" whilst not forgetting our humble past. Thank you for allowing us to share our future with you.More..
SterloMax Rub-in Hand Disinfectants & Sanitizers
SterloMax Is 0.2 Micron filtered, Fast acting and Ready-to-use without water. Pure, hygienic and effective during routine, high risk and outbreak situations For hygienic and surgical hand disinfection, and to sanitize hard porous surfaces Available in 2 variants. Isopropyl alcohol-based and Ethanol-based Disinfectants & Sanitizers
BioPlus Life Sciences is a research driven company, continually evolving and aspires to improve products and service quality through the utilization of the latest technology...
BioPlus's technology for manufacturing sucralose is thus the only alternative novel process that has achieved the specifications of International Standard equal to that of...
We participated the IFT19 at New Orleans, LA form June 3rd to 5th 2019. IFT’s Food Expo attracts over 17,000 attendees and over 90 countries
BioPlus Life Sciences participated the Vitafoods Europe 2017, held at Geneva from May 9 to May 11, 2017. Vitafoods happens to be a global
Glucosamine remains a popular treatment option for osteoarthritis. The recent past has seen a surge
Researchers at Mount Sinai School of Medicine have shown for the first time in an animal model that vitamin C